TrialBlood advances2023

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.

Simone Ferrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.